治疗系统性红斑狼疮新药贝利单抗
摘要
系统性红斑狼疮（SLE）是一种多系统、多器官损害的自身免疫性疾病。在免疫学上最突出的特点是B细胞功能亢进,自发产生大量多克隆免疫球蛋白和自身抗体。
出处
《中国药师》
CAS
2012年第9期1341-1343,共3页
China Pharmacist
参考文献11
-
1Stohl, W, Hilbert DM. The discovery and development of belimum- ab: the anti-BLyS-lupus connection [ J ]. Nat Biotechnol, 2012,30 ( 1 ) : 69-77.
-
2Sanz I, Connective tissue diseases: Targeting B cells in SLE: good news at last [J]. Nat Rev Rheumatol, 2011. 7(5) : 255-256.
-
3Espinosa G, Cervera R. Belimumab, a BLyS-specific inhibitor for the treatment of systemic lupus erythematosus [ J ]. Drugs Today (Barc), 2010,46(12): 891-899.
-
4Furie R, Stohl W, Ginzler EM, et al. Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: a phase I trial in patients with systemic lupus erythematosus [ J]. Arthritis Res Ther,2008,10(5 ) : RIO9.
-
5Benlysta [ EB/OL ] . http ://www. rxlist, com/benlysta-drug, htm, 2011-04-28/2011-12-16.
-
6Wallace DJ, Stohl W, Fufie RA, et al. A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus [ J ]. Arthritis Rheum i2009 ,61 (9) : 1168-1178.
-
7Furie R, Petri M, Zamani O, et al. A phase III, randomized, place- bo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythemato- sus [ J ]. Arthritis Rheum, 2011,63 ( 12 ) : 3918-3930.
-
8Navarra SV, Guzm6n RM, Gallacher AE, et al. Efficacy and safety of belimumab in patients with active systemic lupus erythematosus : arandomised, placebo-controlled, phase 3 trial [ J ]. Lancet,2011,377 (9767) : 721-731.
-
9Wiglesworth AK, Ennis KM, Kockler DR. Belimumab: a BLyS-spe- cific inhibitor for systemic lupus erythematosus [ J ]. Ann Pharmoo- ther,2010,44(12) : 1955-1961.
-
10Vadasz, Z, Toubi E. Belimumab the biological treatment for sys- temic lupus erythematosus first in 50 years [ J ]. Harefuah ,2011, 150(12) : 880-883.
-
1谢婧,史爱欣,胡欣.抗系统性红斑狼疮新药贝利单抗的药理作用及临床评价[J].中国新药杂志,2011,20(16):1483-1486. 被引量：3
-
2刘玉聪,董江萍.治疗红斑狼疮新药:贝利单抗[J].药物评价研究,2011,34(4):305-310. 被引量：1
-
3石永兵,冯胜.狼疮性肾炎的生物靶向治疗[J].临床药物治疗杂志,2012,10(4):18-21. 被引量：5
-
4谭方.85例中药注射剂不良反应分析[J].广西中医学院学报,2010,13(1):48-49. 被引量：2
-
5刘晓军.rIL-2与小鼠抗rIL-2单克隆抗体F（ab′）_2片段的免疫复合可增强其抗[J].药学进展,1995,19(4):222-225.
-
6许静,李保春,于建平,崔若兰,袁伟杰.青霉素和头孢曲松钠致多器官损害一例报告[J].第二军医大学学报,2003,24(1):21-21. 被引量：2
-
7邢爱敏.HGS公司用于治疗系统性红斑狼疮的Benlysta获得Ⅲ期临床试验阳性结果[J].药学进展,2009,33(11):527-528.
-
8金璐燕,艾敏.用于自身免疫性疾病的单克隆抗体——贝利单抗[J].药学进展,2008,32(7):330-332.
-
9黄志兰.苯巴比妥致剥脱性皮炎伴多脏器损害一例[J].天津医药,1997,25(3):160-160.
-
10许家岭,耿仁义,黄振平.小剂量肝素透析在多脏器损害中的应用[J].安徽医学,1998,19(2):25-26.
